ArticleFrontiers in bioinformatics2025

Computational drug repurposing reveals Alectinib as a potential lead targeting Cathepsin S for therapeutic developments against cancer and chronic pain.

Mohammed Alrouji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.